Related references
Note: Only part of the references are listed.Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms
Khojasteh Malekmohammad et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
M1 Macrophage Derived Exosomes Aggravate Experimental Autoimmune Neuritis via Modulating Th1 Response
Tong Du et al.
FRONTIERS IN IMMUNOLOGY (2020)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production
Ilgin Cagnan et al.
STEM CELL REVIEWS AND REPORTS (2018)
Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production
Ilgin Cagnan et al.
STEM CELL REVIEWS AND REPORTS (2018)
Regulatory T cells as a new therapeutic target for atherosclerosis
Han-xiao Ou et al.
ACTA PHARMACOLOGICA SINICA (2018)
Regulation of macrophage immunometabolism in atherosclerosis
Graeme J. Koelwyn et al.
NATURE IMMUNOLOGY (2018)
Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice
Takuya Matsumoto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis
Dipica Haribhai et al.
JOURNAL OF IMMUNOLOGY (2016)
Disruption of the TSLP-TSLPR-LAP signaling between epithelial and dendritic cells through hyperlipidemia contributes to regulatory T-Cell defects in atherosclerotic mice
Kunwu Yu et al.
ATHEROSCLEROSIS (2015)
The immunosuppressive enzyme IL4I1 promotes FoxP3+ regulatory T lymphocyte differentiation
Celine Cousin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance
Andre P. da Cunha et al.
INTERNATIONAL IMMUNOLOGY (2015)
IL4I1 Is a Novel Regulator of M2 Macrophage Polarization That Can Inhibit T Cell Activation via L-Tryptophan and Arginine Depletion and IL-10 Production
Yinpu Yue et al.
PLOS ONE (2015)
Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3- T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells
M. Scurr et al.
MUCOSAL IMMUNOLOGY (2014)
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis
Roland Klingenberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Downregulation of CD4+LAP+ and CD4+CD25+ Regulatory T Cells in Acute Coronary Syndromes
Ying-zhong Lin et al.
MEDIATORS OF INFLAMMATION (2013)
Cytokine Therapy With Interleukin-2/Anti-Interleukin-2 Monoclonal Antibody Complexes Expands CD4+CD25+Foxp3+ Regulatory T Cells and Attenuates Development and Progression of Atherosclerosis
Tam Nguyen Dinh et al.
CIRCULATION (2012)
Administration of CD4+CD25highCD127- Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children
Natalia Marek-Trzonkowska et al.
DIABETES CARE (2012)
Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype
Larissa Cardilo-Reis et al.
EMBO MOLECULAR MEDICINE (2012)
Inducible CD4+LAP+Foxp3- Regulatory T Cells Suppress Allergic Inflammation
Wei Duan et al.
JOURNAL OF IMMUNOLOGY (2011)
HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells
Jonathan E. Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice
Emily Smith et al.
CIRCULATION (2010)
Cutting Edge: Human Latency-Associated Peptide+ T Cells: A Novel Regulatory T Cell Subset
Roopali Gandhi et al.
JOURNAL OF IMMUNOLOGY (2010)
Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice
Yaron Ilan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice
Naoto Sasaki et al.
CIRCULATION (2009)
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Greg M. Delgoffe et al.
IMMUNITY (2009)
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β-dependent manner
John Andersson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Latency Associated Peptide Has In Vitro and In Vivo Immune Effects Independent of TGF-β1
Naeem A. Ali et al.
PLOS ONE (2008)
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Christian Weber et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody
Hiroki Ishikawa et al.
DIABETES (2007)
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis
Adi Mor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule
Israel Gotsman et al.
CIRCULATION (2006)
Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25-LAP+ T cells
Hirofumi Ochi et al.
NATURE MEDICINE (2006)
Natural regulatory T cells control the development of atherosclerosis in mice
H Ait-Oufella et al.
NATURE MEDICINE (2006)
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
PJ Gough et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis
XH Zhou et al.
CIRCULATION RESEARCH (2005)
Making sense of latent TGFβ activation
JP Annes et al.
JOURNAL OF CELL SCIENCE (2003)
Share Paper
